• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人C1酯酶抑制剂的纯化与特性分析

Purification and characterization of human C1-esterase inhibitor.

作者信息

Nilsson T, Wiman B

出版信息

Biochim Biophys Acta. 1982 Jul 26;705(2):271-6. doi: 10.1016/0167-4838(82)90188-1.

DOI:10.1016/0167-4838(82)90188-1
PMID:6981429
Abstract

A new purification method for C1-esterase inhibitor is described, which is essentially a three-step procedure: precipitation with poly(ethylene glycol), chromatography on DEAE-cellulose and hydrophobic interaction chromatography on hexyl-Sepharose. The final product is a single-chain glycoprotein with a molecular weight of about 100 000 and NH2-terminal asparagine. The molecule is fully active as judged by complex formation with C1s. Two of its three disulphide bridges can be easily reduced and S-carboxymethylated under non-denaturing conditions without loss of activity. However, at high dithioerythritol concentration the third disulphide bridge is also cleaved and accompanied by loss of the activity, indicating that this disulphide bridge is involved in maintaining the conformation around the reactive site in the inhibitor.

摘要

本文描述了一种新的C1酯酶抑制剂纯化方法,该方法主要包括三个步骤:用聚乙二醇沉淀、在DEAE-纤维素上进行层析以及在己基琼脂糖上进行疏水相互作用层析。最终产物是一种单链糖蛋白,分子量约为100000,氨基末端为天冬酰胺。根据与C1s形成复合物的情况判断,该分子具有完全活性。在非变性条件下,其三个二硫键中的两个可以很容易地被还原并进行S-羧甲基化,而不会丧失活性。然而,在高浓度二硫苏糖醇的情况下,第三个二硫键也会被切断,并伴随着活性丧失,这表明该二硫键参与维持抑制剂活性位点周围的构象。

相似文献

1
Purification and characterization of human C1-esterase inhibitor.人C1酯酶抑制剂的纯化与特性分析
Biochim Biophys Acta. 1982 Jul 26;705(2):271-6. doi: 10.1016/0167-4838(82)90188-1.
2
Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.关于人C1酯酶抑制剂与C1s相互作用的结构和圆二色性研究
Biochem J. 1983 Sep 1;213(3):617-24. doi: 10.1042/bj2130617.
3
A new simple method for determination of C1-esterase inhibitor activity in plasma.一种测定血浆中C1酯酶抑制剂活性的新的简单方法。
Clin Chim Acta. 1983 Mar 14;128(2-3):359-66. doi: 10.1016/0009-8981(83)90335-2.
4
[New preparation method of C1 esterase for the dosage of its plasma inhibitor].[用于血浆抑制剂剂量的C1酯酶新制备方法]
Biomed Pharmacother. 1983;37(5):228-30.
5
Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.人补体成分C1s。重链部分序列测定及激活过程中裂解的肽键鉴定。
Eur J Biochem. 1986 Apr 1;156(1):49-57. doi: 10.1111/j.1432-1033.1986.tb09546.x.
6
Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.Hep G2细胞对补体C1抑制因子的生物合成。该抑制因子不同糖基化形式与C1s的反应性。
Biochem J. 1986 Jul 1;237(1):93-8. doi: 10.1042/bj2370093.
7
Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
Eur J Biochem. 1983 Jan 1;129(3):663-7. doi: 10.1111/j.1432-1033.1983.tb07100.x.
8
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.当C1抑制剂的反应中心被血浆激肽释放酶、活化的因子XII片段、C1酯酶或中性粒细胞弹性蛋白酶切割时,会产生一种常见的新表位。
J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650.
9
Primary structure of the reactive site of human C1-inhibitor.人C1抑制剂反应位点的一级结构。
J Biol Chem. 1985 Feb 25;260(4):2432-6.
10
Proteolytic cleavage of an activated subcomponent of the first component of rabbit complement, C1s.兔补体第一成分C1s的活化亚成分的蛋白水解裂解
J Biochem. 1980 Jun;87(6):1757-63. doi: 10.1093/oxfordjournals.jbchem.a132920.

引用本文的文献

1
Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.关于人C1酯酶抑制剂与C1s相互作用的结构和圆二色性研究
Biochem J. 1983 Sep 1;213(3):617-24. doi: 10.1042/bj2130617.
2
Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.牙龈卟啉单胞菌对血浆蛋白酶级联系统关键因子的失活作用
Infect Immun. 1985 Nov;50(2):467-71. doi: 10.1128/iai.50.2.467-471.1985.
3
Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
通过酶联免疫吸附测定法测定血浆中的C1s-C1抑制剂复合物。
Clin Exp Immunol. 1985 Apr;60(1):178-82.
4
Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.在C1抑制剂缺乏患者血浆中证实补体(C1)抑制剂的修饰失活第一成分。
J Clin Invest. 1986 Aug;78(2):567-75. doi: 10.1172/JCI112610.
5
Aspects of C1-inhibitor biochemistry and pathophysiology.C1抑制剂的生物化学与病理生理学方面
Clin Rheumatol. 1987 Sep;6(3):332-9. doi: 10.1007/BF02206831.